Literature DB >> 16688636

From spreading depression to the trigeminovascular system.

T Dalkara1, N T Zervas, M A Moskowitz.   

Abstract

Migraine headaches have a complex pathophysiology; both vascular and neuronal mechanisms have been proposed. One possible scenario begins with brain-initiated events evolving to cortical spreading depression (CSD), which in turn activates the trigeminal nerve to cause headaches. Experimental evidence supports a relationship between CSD as a cause of migraine aura as well as CSD as a cause of trigeminal activation. Susceptibility to CSD and to migraine appears to be genetically determined. In some migraine subtypes, genes controlling translocation of calcium, sodium and potassium have been implicated, perhaps altering the susceptibility to CSD. This chapter briefly reviews current knowledge pertaining to migraine pathophysiology with emphasis on current notions linking disturbances in ion flux to the genesis of headache.

Entities:  

Mesh:

Year:  2006        PMID: 16688636     DOI: 10.1007/s10072-006-0577-z

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  31 in total

Review 1.  Migraine and obesity: epidemiology, possible mechanisms and the potential role of weight loss treatment.

Authors:  D S Bond; J Roth; J M Nash; R R Wing
Journal:  Obes Rev       Date:  2011-05       Impact factor: 9.213

2.  Triptan-induced enhancement of neuronal nitric oxide synthase in trigeminal ganglion dural afferents underlies increased responsiveness to potential migraine triggers.

Authors:  Milena De Felice; Michael H Ossipov; Ruizhong Wang; Gregory Dussor; Josephine Lai; Ian D Meng; Juliana Chichorro; John S Andrews; Suman Rakhit; Shawn Maddaford; David Dodick; Frank Porreca
Journal:  Brain       Date:  2010-07-13       Impact factor: 13.501

Review 3.  Modelling headache and migraine and its pharmacological manipulation.

Authors:  S E Erdener; T Dalkara
Journal:  Br J Pharmacol       Date:  2014-07-01       Impact factor: 8.739

Review 4.  Neurogenic inflammation and its role in migraine.

Authors:  Roshni Ramachandran
Journal:  Semin Immunopathol       Date:  2018-03-22       Impact factor: 9.623

5.  Association between Chlamydia pneumoniae IgG antibodies and migraine.

Authors:  QiHong Lu; Jinzh Xu; HongYan Liu
Journal:  J Headache Pain       Date:  2009-02-24       Impact factor: 7.277

Review 6.  Impact of mast cells in depression disorder: inhibitory effect of IL-37 (new frontiers).

Authors:  Pio Conti; Alessandro Caraffa; Gianpaolo Ronconi; Chiara M Conti; Spiros K Kritas; Filiberto Mastrangelo; Lucia Tettamanti; Theoharis C Theoharides
Journal:  Immunol Res       Date:  2018-06       Impact factor: 2.829

Review 7.  Migraine in the era of precision medicine.

Authors:  Lv-Ming Zhang; Zhao Dong; Sheng-Yuan Yu
Journal:  Ann Transl Med       Date:  2016-03

8.  Investigation of the immunoreactivities of NOS enzymes and the effect of sumatriptan in adolescent rats using an experimental model of migraine.

Authors:  Semra Hiz Kurul; Savas Demirpence; Müge Kiray; Kazim Tugyan; Osman Yilmaz; Galip Kose
Journal:  J Headache Pain       Date:  2008-08-08       Impact factor: 7.277

9.  Reactive oxygen species induce procalcitonin expression in trigeminal ganglia glia.

Authors:  Ann C Raddant; Andrew F Russo
Journal:  Headache       Date:  2014-02-11       Impact factor: 5.887

Review 10.  Mechanisms involved in the cerebrovascular dilator effects of cortical spreading depression.

Authors:  David W Busija; Ferenc Bari; Ferenc Domoki; Takashi Horiguchi; Katsuyoshi Shimizu
Journal:  Prog Neurobiol       Date:  2008-09-12       Impact factor: 11.685

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.